This test is most useful if any of these apply to you.
If you have ever reacted to hazelnut and wondered how serious the next reaction could be, the protein your immune system is fixed on matters more than a yes-or-no allergy result. Cor a 11 is one of several proteins inside a hazelnut that can trigger an allergic response, and the type of protein driving your reaction tends to predict how the reaction shows up.
This is a component-level allergy test, meaning it zooms in on one specific hazelnut protein rather than the whole nut. The clinical evidence on Cor a 11 (Corylus avellana allergen 11) is still developing, but in at least one pediatric study, higher levels were tied to more severe reactions during a supervised hazelnut food challenge.
Cor a 11 is a 7S vicilin-type seed storage protein. In plain terms, it is part of the hazelnut's built-in food supply for its own seed. Storage proteins like this are not destroyed easily by stomach acid or cooking, which is one reason allergy researchers pay attention to them: they tend to survive long enough to reach the immune system intact.
Cor a 11 IgE (immunoglobulin E) measures the antibodies your immune system has built against this specific protein. The antibody itself is produced by immune cells called B cells, not by any organ. A positive result means your body recognizes Cor a 11 and is primed to release allergic mediators when it encounters the protein again.
Hazelnut allergy is not one thing. Different people react because of different proteins inside the nut, and each protein carries a different reputation for severity.
| Hazelnut Protein | What It Signals | How It Tends to Present |
|---|---|---|
| Cor a 1 | Birch-pollen-related sensitivity | Often mild oral symptoms |
| Cor a 8 | Lipid transfer protein, common in Mediterranean populations | Can drive systemic reactions |
| Cor a 9 and Cor a 14 | Seed storage proteins | Strongly tied to true, sometimes severe hazelnut allergy in children |
| Cor a 11 | Seed storage protein, minor allergen overall | Cohort-specific link to severity, less validated than Cor a 9 or 14 |
Across European cohorts, Cor a 11 sensitization has been reported most often in Mediterranean patients, though it has also been found in children with systemic reactions in birch-endemic regions. It is considered a minor allergen overall. Most people with clinically meaningful hazelnut allergy are sensitized to Cor a 9, Cor a 14, or Cor a 8 instead. Cor a 11 adds context, not a stand-alone diagnosis.
In a Spanish pediatric study, levels of Cor a 11 and Cor a 14 were significantly higher in children who had more severe reactions during a supervised hazelnut oral food challenge compared with milder reactors. Cor a 11 was described as one of the more frequent storage proteins found in this group, though in most other cohorts Cor a 9 and Cor a 14 are recognized far more often than Cor a 11.
What this means for you: a positive Cor a 11 result, especially alongside positive Cor a 9 or Cor a 14, raises the possibility that any future reaction is more likely to involve symptoms beyond the mouth and throat. It does not guarantee a severe reaction will happen, but it shifts the risk picture.
Laboratory work on patients sensitized to both peanut and hazelnut found that Cor a 11 can cross-react with peanut storage proteins at the antibody level. If you already know you are peanut-allergic, a positive Cor a 11 may reflect this cross-talk rather than a fully separate hazelnut allergy, which is one reason the result should be interpreted alongside your clinical history.
Cor a 11 sits in the third tier of allergy testing maturity. Diagnostic accuracy studies have focused mainly on Cor a 9 and Cor a 14, where evidence is stronger and standardized cutoffs exist for ruling allergy in or out. Cor a 11 does not yet have validated thresholds, and a Spanish pediatric study, the EuroPrevall outpatient survey of 731 hazelnut-reactive subjects (with sera from 423 analyzed for component IgE), and a U.S. dataset of more than 10,000 hazelnut-sensitized people all treat it as a supplementary marker.
That said, a negative Cor a 11 does not clear you of hazelnut allergy. People with severe reactions can be negative for Cor a 11 while strongly positive for Cor a 9 or Cor a 14. The component panel is meant to be read together, not piece by piece.
Specific IgE results are best interpreted as part of a trajectory, not a snapshot. In children, sensitization patterns shift with age, with storage protein reactivity often persisting while pollen-related sensitivities can fade or appear. If you are using a test like this to track whether your immune profile is changing, a baseline now and a follow-up in 6 to 12 months gives you something to compare. If you are doing nothing differently, annual retesting is reasonable.
Available studies treat these IgE values as relatively stable markers across days and weeks, not numbers that swing day to day. There is no published evidence that short-term factors like recent illness, heavy exercise, or pre-test diet meaningfully shift Cor a 11 IgE in the 1 to 3 days before a blood draw. Allergy guidelines also confirm that antihistamines do not interfere with specific IgE blood testing, though one study suggested longer courses of antihistamines may lower total IgE over a month.
A few things to keep in mind when reading a Cor a 11 result:
If your Cor a 11 IgE is positive, the most useful next step is rarely a repeat blood test. It is to put this result in context with the rest of the hazelnut component panel and your clinical history. A few patterns worth recognizing:
Across the published evidence, a key message keeps repeating: blood IgE results, including component-resolved testing, cannot fully replace a supervised oral food challenge when the diagnosis is genuinely uncertain. The blood test narrows the question. The challenge answers it.
Hazelnut (Cor a 11) IgE is best interpreted alongside these tests.
Hazelnut (Cor a 11) IgE is included in these pre-built panels.